ELISA Kit for Transgelin 2 (TAGLN2)

Epididymis tissue protein Li 7e; SM22-alpha homolog


This assay has high sensitivity and excellent specificity for detection of Transgelin 2 (TAGLN2).
No significant cross-reactivity or interference between Transgelin 2 (TAGLN2) and analogues was observed.


Matrices listed below were spiked with certain level of recombinant Transgelin 2 (TAGLN2) and the recovery rates were calculated by comparing the measured value to the expected amount of Transgelin 2 (TAGLN2) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 93-105 101
EDTA plasma(n=5) 85-101 91
heparin plasma(n=5) 98-105 102


Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Transgelin 2 (TAGLN2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Transgelin 2 (TAGLN2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%


The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Transgelin 2 (TAGLN2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 89-99% 97-104% 91-105% 78-105%
EDTA plasma(n=5) 96-104% 78-89% 87-95% 78-89%
heparin plasma(n=5) 90-97% 88-98% 97-105% 86-99%


The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.



Magazine Citations
Discovery medicine Combined serum and EPS-urine proteomic analysis using iTRAQ technology for discovery of potential prostate cancer biomarkers. pubmed:28009970
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPF790Hu01 Recombinant Transgelin 2 (TAGLN2) Positive Control; Immunogen; SDS-PAGE; WB.
PAF790Hu01 Polyclonal Antibody to Transgelin 2 (TAGLN2) WB; IHC; ICC; IP.
MAF790Hu21 Monoclonal Antibody to Transgelin 2 (TAGLN2) WB; IHC; ICC; IP.
SEF790Hu ELISA Kit for Transgelin 2 (TAGLN2) Enzyme-linked immunosorbent assay for Antigen Detection.
CGF790Hu01 cDNA of Transgelin 2 (TAGLN2) PCR; Protein Expression; etc.